Latest ERN GUARD-Heart Publications:
Published Newsletter Nr 1 2026:
Published Newsletter Nr 5 2025:
1.Fulvio G, Marinello D, Zucchi D, Aguilera S, Benachi A, Biller R, Blanco I, Boiteux MC, Borgards P, Brandi ML, Costafreda E, Fonseca JE, Fredi M, Guimarães V, Iotova V, Lecointe-Artzner E, Lopes AR, Louisse S, Nalli C, Olesinska M, Onali M, Papenthin W, Power B, Röhl C, Rousset-Jablonski C, Sturz D, Tincani A, van Vleuten CJ, Vieira A, Dan D, Backer J, Smulders CD, Dufke A, Frank C, Limongelli G, Lorenz B, Kilpiäinen E, Pascau MJ, Raidt J, Ray-Coquard I, Rimmer R, Schneider H, Van Pal HJ, Yap T, Talarico R, Tani C, Mosca M. Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the “ERN transversal working group on pregnancy and family planning” survey. Reprod Health. 2025 Nov 25;22(1):240. doi: 10.1186/s12978-025-02136-5. PMID: 41291857. Read article
2.Garcia-Pavia P, Gonzalez-Lopez E, Anderson LJ, Cappelli F, Damy T, Fontana M, Gonzalez-Costello J, Jurcut R, Lairez O, van der Meer P, Merlo M, Perlini S, Bayes-Genis A. Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association. Eur Heart J. 2025 Oct 7:ehaf710. doi: 10.1093/eurheartj/ehaf710. Epub ahead of print. PMID: 41055898. Read article
3.Desai MY, Maurizi N, Biagini E, Charron P, Fernandes F, González-López E, van Haelst PL, Haugaa KH, Kramer CM, Meder B, Michels M, Owens A, Yuasa S, Elliott P. Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Nov;13(11):102658. doi: 10.1016/j.jchf.2025.102658. Epub 2025 Sep 24. PMID: 40997544.
4.Jurcut R, Barriales-Villa R, Biagini E, Garcia-Pavia P, Olivotto I, Protonotarios A, Arbustini E, Mogensen J, Elliott P, Arbelo E, Kaski JP; Members of the Task Force for the 2023 ESC Guidelines for the management of cardiomyopathies. Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings. Eur Heart J Qual Care Clin Outcomes. 2025 Nov 4;11(7):910-918. doi: 10.1093/ehjqcco/qcae103. PMID: 39657995.
5.Campuzano O, Tirón C, Martínez-Barrios E, Greco A, Cruzalegui J, Chipa F, Cesar S, Merchan EF, Coll M, Fernández-Falgueras A, Brugada R, Ortega M, Molina N, Barberia E, Toro R, Oliva A, Grassi S, Sarquella-Brugada G. The Role of Molecular Autopsy in Concealed Cardiomyopathies. Genes (Basel). 2025 Oct 28;16(11):1273. doi: 10.3390/genes16111273. PMID: 41300724.
6.O’Neill MJ, Ma JG, Aldridge JL, Solus JF, Harvey GR, Roberson PH, Barc J, Bezzina CR, Roden DM, Walsh R, Vandenberg JI, Glazer AM, Ng CA. Automated patch clamp data improve variant classification and penetrance stratification for SCN5A-Brugada syndrome. Eur Heart J. 2025 Nov 18:ehaf874. doi: 10.1093/eurheartj/ehaf874. Epub ahead of print. PMID: 41251004.
7.Venner MFGHM, Heymans ABM, Beelen NJ, Stroeks SLVM, Faassen IME, Sikking MA, Henkens MTHM, van der Crabben SN, Raafs AG, Heymans SRB, Verdonschot JAJ. Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy. Europace. 2025 Oct 31;27(11):euaf279. doi: 10.1093/europace/euaf279. PMID: 41206691; PMCID: PMC12619085.
8.Sikking M, Wiethoff I, Henkens M, Evers S, Stroeks S, Venner M, Weerts J, Brunner-la Rocca HP, Knackstedt C, van Empel V, Michels M, Heymans S, Hiligsmann M, Verdonschot J. High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Qual Life Res. 2025 Oct;34(10):2901-2910. doi: 10.1007/s11136-025-04027-5. Epub 2025 Jul 30. PMID: 40739074; PMCID: PMC12535485.
9.Francia P, Falasconi G, Musumeci MB, Biagini E, Freitas P, Penela D, Ortiz-Pérez JT, Tini G, Sclafani M, Schiavo MA, Amador R, Carli S, Del Monaco G, Panico C, Soto-Iglesias D, Franco-Ocaña P, Ditaranto R, Saglietto A, Martì-Almor J, Autore C, Berruezo A. Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance Study. Eur Heart J Cardiovasc Imaging. 2025 Oct 28:jeaf297. doi: 10.1093/ehjci/jeaf297. Epub ahead of print. PMID: 41150638.